Actualizaciones regulatorias30 ago 2026•1 min de lectura

FDA Discontinues Isoniazid Tablet (ANDA083060)

Por el equipo de PharmaCountry

FDA lists the oral Isoniazid 100 mg tablet from sponsor PERRIGO (ANDA083060) as discontinued, with no reference drug status.

The U.S. Food and Drug Administration (FDA) has issued a status update for an abbreviated new drug application (ANDA) identified as ANDA083060. The application concerns an oral tablet product named Isoniazid, 100 mg strength, manufactured by PERRIGO. The product is listed with a marketing status of “Discontinued” and is not designated as a reference drug or reference standard.

Recopilado por el equipo de PharmaCountry · Fuente: FDA.gov

Temas:#Isoniazid #ANDA #FDA #discontinuation #Oral Tablet #pharmaceutical regulation